MiR-361-5p suppresses chemoresistance of gastric cancer cells by targeting FOXM1 via the PI3K/Akt/mTOR pathway

Gastric cancer is a prevalent cancer and chemotherapy is a main treatment for patients. Docetaxel is commonly used as a chemotherapeutic drug for gastric cancer patients. With the increasing emergence of docetaxel resistance, exploring the mechanism of chemoresistance may improve prognosis of patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Lei, Zhao, Zhifeng, Xie, Ling, Zhu, JinPeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797020/
https://www.ncbi.nlm.nih.gov/pubmed/29435149
http://dx.doi.org/10.18632/oncotarget.23513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797020/
https://www.ncbi.nlm.nih.gov/pubmed/29435149
http://dx.doi.org/10.18632/oncotarget.23513

Ejemplares similares